Key Findings:  The ECS and corresponding ligands may represent novel therapeutic mechanisms in the treatment of autism.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  Ethiopia, United States
Year of Pub:  2022
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabidivarin (CBDV)
Phytocannabinoid Source:  Unspecified
Citation:  Babayeva M, et al. Autism and associated disorders: cannabis as a potential therapy. Front Biosci (Elite Ed). 2022; 14:1. doi: 10.31083/j.fbe1401001
Authors:  Babayeva M, Assefa H, Basu P, Loewy Z